Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05491915 · ClinicalTrials.gov registry record · NA

The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain

A NA study of Cervicogenic Headache and Occipital Neuralgia, sponsored by SPR Therapeutics.

Active
Registry status
NA
Development phase
50
Enrollment target
10
Study locations

NCT05491915 is a NA study of Cervicogenic Headache and Occipital Neuralgia that is active but no longer recruiting, run by SPR Therapeutics. The registered enrollment target is 50 participants, below the 58-participant average among 4 other Cervicogenic Headache trials with a reported enrollment target (14% lower). The trial reports 10 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05491915, a NA study of Cervicogenic Headache and Occipital Neuralgia, is active but no longer recruiting, sponsored by SPR Therapeutics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
10
Study locations

Study Summary

The purpose of this study is to learn if pain can be relieved by delivering small amounts of electricity (called "electrical stimulation") to the nerves at the top of the neck. This study will use a device called the SPRINT® PNS System. PNS stands for peripheral nerve stimulation (PNS). This device is cleared by the FDA for up to 60 days of use for relief of chronic or acute pain.

Conditions Studied

Cervicogenic Headache Occipital Neuralgia

Interventions

  • DEVICE SPRINT Peripheral Nerve Stimulation (PNS) System

Study Locations (10)

Texas

  • Pain Specialists of America - South Austin - James Casey - Austin
  • Pain Specialists of America - Cedar Park - Cedar Park
  • Institute of Precision Pain Medicine - Corpus Christi
  • Pain Specialists of America - Round Rock - Round Rock
  • Pain Specialists of America - San Marcos - San Marcos

California

  • Pacific Research Institute - Santa Rosa

Massachusetts

  • MedVadis Research - Waltham

Minnesota

  • Mayo Clinic Rochester - Rochester

North Carolina

  • Center of Clinical Research - Winston-Salem

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-10-24
Est. Completion 2027-08
Phase NA

Sponsor

SPR Therapeutics

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05491915

The ClinicalTrials.gov registry entry for NCT05491915 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 4 other Cervicogenic Headache trials with a reported enrollment target (14% lower). The listed sponsor is SPR Therapeutics, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cervicogenic Headache appearing as the primary indexed condition, and to 1 intervention - of which SPRINT Peripheral Nerve Stimulation (PNS) System is the first listed.

NCT05491915 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Texas, California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05491915 about?

NCT05491915 is a clinical study titled "The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain". The purpose of this study is to learn if pain can be relieved by delivering small amounts of electricity (called "electrical stimulation") to the nerves at the top of the neck. This study will use a device called the SPRINT® PNS System. PNS stands for peripheral nerve stimulation (PNS). This device ...

What is the current status of trial NCT05491915?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-10-24. Estimated completion is 2027-08.

What conditions does trial NCT05491915 study?

This clinical trial studies the following conditions: Cervicogenic Headache, Occipital Neuralgia.

What interventions are being tested in trial NCT05491915?

The interventions under investigation include: SPRINT Peripheral Nerve Stimulation (PNS) System (DEVICE).

Who is sponsoring clinical trial NCT05491915?

This trial is sponsored by SPR Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05491915 being conducted?

This trial has 10 study locations across California, Massachusetts, Minnesota, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cervicogenic Headache

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cervicogenic Headache

All registered trials for this condition

Occipital Neuralgia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.